These cancers express basal/myoepithelial cell markers such as cytokeratins 5/6, 14 and 17 or vimentin [37-39] but do not express ESR1, progesterone receptor (PRGR) or ERBB2 (triple negative) [37]. Here, ESR1 is linked to cancer.